pfizer glp-1 pipeline Argus Turns Bullish on (PFE), Highlights and Oncology Pfizer's embattled obesity program loses

The FDA stated it received an unspecified number of adverse event reports linked to compounded semaglutide that were due to dosing errors

Type 2 diabetes is a chronic metabolic disease, even when blood sugar improves significantly, says Randa Abdelmasih, MD, an assistant professor of medicine in the division of endocrinology and metabolism at the University of Texas Medical Branch in Galveston

Symptoms may include rash, itching, flushing, or hives, with more severe cases potentially involving swelling of the face , tongue, or throat

GLP-1 drugs offer a powerful tool for individuals struggling with obesity who may not be candidates for surgery or who have not achieved success with lifestyle modifications alone

Protein ve lif kaynaklarnn nn banda tketilmesi, karbonhidratlarn daha dengeli emilmesine yardmc olabilir